Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Breast Cancer Stage IVOligometastatic Disease
Interventions
RADIATION

SABR

Stereotactic Ablative Radiotherapy is delivered to all metastatic lesions.

Trial Locations (1)

41345

RECRUITING

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Azienda Ospedaliero-Universitaria Careggi

OTHER

collaborator

Region Örebro County

OTHER

collaborator

Skane University Hospital

OTHER

collaborator

Uppsala University Hospital

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

University Hospital, Umeå

OTHER

collaborator

Sundsvall Hospital

OTHER

collaborator

Karlstad Central Hospital

OTHER

collaborator

Gävle Hospital

OTHER

collaborator

Centrallasarettet Västerås

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

St. Olavs Hospital

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

University of Stavanger

OTHER

collaborator

University Hospital of North Norway

OTHER

lead

Vastra Gotaland Region

OTHER_GOV